National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 6/4/2021 release of VAERS data:

This is VAERS ID 1266019

Case Details

VAERS ID: 1266019 (history)  
Form: Version 2.0  
Age: 50.0  
Sex: Female  
Location: Oregon  
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-04-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Unknown       Purchased by: ?
Symptoms: Abdominal pain upper, Diarrhoea, Rectal haemorrhage
SMQs:, Acute pancreatitis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Pseudomembranous colitis (broad), Gastrointestinal haemorrhage (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Ischaemic colitis (broad), Noninfectious diarrhoea (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Asthma; Contrast media allergy; Lung neoplasm malignant; Shellfish allergy
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2021414761

Write-up: This is a spontaneous report from a contactable consumer (patient). A 50-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EW0151; Expiration date was not reported) on the left arm on 06Apr2021 (15:00) as a single dose, with route of administration unspecified, for COVID-19 immunization. Medical history included neuroendocrine lung cancer, asthma, and allergies to shellfish and IV contrast dye. The patient''s concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient had previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EP7534; Expiration date was not reported) on 15Mar2021 (when the patient was 50 years old) for COVID-19 immunization. On 11Apr2021 (03:00), the patient had rectal bleeding, stomach cramps and diarrhea. The events were assessed as serious (medically significant), and had resulted into an emergency room/department or urgent care. The patient had received unspecified intravenous (IV) fluids as treatment for the reported events. The outcome of the events was recovering. The patient was not diagnosed with COVID-19 prior to vaccination, and had not been tested post-vaccination.

New Search

Link To This Search Result:

Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166